[425] Sonnet BioTherapeutics Holdings, Inc. Business Combination Communication

Rhea-AI Filing Summary

Analyzing...

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Filed by Hyperliquid Strategies Inc

pursuant to Rule 425 under the Securities Act of 1933

and deemed filed pursuant to Rule 14a-12

under the Securities Exchange Act of 1934

Subject Company: Sonnet BioTherapeutics Holdings, Inc.

Commission File No. 001-35570

Date: November 18, 2025